CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases
Iwona Szymkiewicz1, Katarzyna Kowanetz, Philippe Soubeyran
1Ludwig Institute for Cancer Research, Box 595, Husargatan 3, Uppsala, S-75124, Sweden.
Abstract:
The Cbl family of ubiquitin ligases in mammals contains three members, Cbl, Cbl-b, and Cbl-3, that are involved in down-regulation of receptor tyrosine kinases (RTKs) by mediating receptor ubiquitination and degradation. More recently, a novel pathway has been identified whereby Cbl promotes internalization of EGF receptor via a CIN85/endophilin pathway that is functionally separable from the ubiquitin ligase activity of Cbl (1). Here we show that Cbl-b, but not Cbl-3, utilize the same mechanism to down-regulate multiple RTKs. CIN85 was shown to bind to the minimal binding domain identified in the carboxyl terminus of Cbl-b. Ligand-induced phosphorylation of Cbl-b further increased their interactions and led to a rapid and sustained recruitment of CIN85 in the complex with EGF or PDGF receptors. Inhibition of binding between CIN85 and Cbl-b was sufficient to impair Cbl-b-mediated internalization of EGF receptors, while being dispensable for Cbl-b-directed polyubiquitination of EGF receptors. Moreover, CIN85 and Cbl/Cbl-b were constitutively associated with activated PDGF, EGF, or c-Kit receptors in several tumor cell lines. Our data reveal a common pathway utilized by Cbl and Cbl-b that may have an important and redundant function in negative regulation of ligand-activated as well as oncogenically activated RTKs in vivo.
Insights
The Cbl-b protein regulates receptor tyrosine kinases (RTKs) through a pathway involving CIN85, distinct from its ubiquitin ligase activity. This mechanism is crucial for down-regulating RTKs in both normal and cancer cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The Cbl family of ubiquitin ligases (Cbl, Cbl-b, Cbl-3) regulates receptor tyrosine kinases (RTKs) via ubiquitination and degradation.
- A novel Cbl-mediated pathway involving CIN85/endophilin facilitates EGF receptor internalization, separate from its ligase function.
Purpose of the Study:
- To investigate if Cbl-b utilizes the CIN85/endophilin pathway for RTK down-regulation.
- To elucidate the role of CIN85 in Cbl-b-mediated receptor internalization and RTK regulation.
Main Methods:
- Investigated Cbl-b interactions with CIN85 using binding assays.
- Analyzed the effect of CIN85-Cbl-b binding inhibition on EGF receptor internalization.
- Examined the association of CIN85, Cbl/Cbl-b with activated RTKs in tumor cell lines.
Main Results:
- Cbl-b, but not Cbl-3, uses the CIN85/endophilin pathway to down-regulate multiple RTKs.
- CIN85 binds to Cbl-b's carboxyl terminus; phosphorylation enhances this interaction.
- Inhibiting CIN85-Cbl-b binding impairs Cbl-b-mediated EGF receptor internalization but not ubiquitination.
- CIN85 and Cbl/Cbl-b associate with activated PDGF, EGF, and c-Kit receptors in tumor cells.
Conclusions:
- Cbl-b employs a common pathway with Cbl for RTK internalization via CIN85.
- This pathway plays a significant and potentially redundant role in negatively regulating activated RTKs in vivo.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization
TGF - β Signaling Pathway
Receptor Tyrosine Kinases
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

